Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LIFECORE BIOMEDICAL, INC. \DE\ Director's Dealing 2016

Mar 24, 2016

33431_dirs_2016-03-24_d62f88df-2329-4147-83e0-99129623e07e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2016-03-21

Reporting Person: SKINNER GREGORY S (VP Finance and Admin & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-03-21 Common Stock M 22500 $6.22 Acquired 256443 Direct
2016-03-21 Common Stock M 12815 $10.92 Disposed 243628 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-03-21 Incentive Stock Option (right to buy) $10.92 X 22500 Disposed 2016-05-21 Common Stock (22500) Direct

Footnotes

F1: Mr Skinner surrendered to the Issuer the right to receive an aggregate of 12,815 shares of Common Stock. Mr. Skinner did not sell any shares of Common Stock in connection with the foregoing exercise.